The use of a new topical hemostatic agent. 1980

M R Wirthlin, and A R Vernino, and E B Hancock

MICROFIBRILLARY COLLAGEN hemostat (MCH) is described in clinical use as a topical hemostatic agent for control of bleeding at the donor site of the free gingival graft procedures. On the basis of clinical trials, it is an excellent adjunct to periodontal surgical procedures.

UI MeSH Term Description Entries
D009061 Mouth Mucosa Lining of the ORAL CAVITY, including mucosa on the GUMS; the PALATE; the LIP; the CHEEK; floor of the mouth; and other structures. The mucosa is generally a nonkeratinized stratified squamous EPITHELIUM covering muscle, bone, or glands but can show varying degree of keratinization at specific locations. Buccal Mucosa,Oral Mucosa,Mucosa, Mouth,Mucosa, Oral
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D005881 Gingiva Oral tissue surrounding and attached to TEETH. Gums,Interdental Papilla,Papilla, Interdental,Gum
D006490 Hemostatics Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. Antihemorrhagic,Hemostatic,Antihemorrhagics
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D014182 Transplantation, Autologous Transplantation of an individual's own tissue from one site to another site. Autografting,Autologous Transplantation,Autotransplantation,Autograftings,Autologous Transplantations,Autotransplantations,Transplantations, Autologous

Related Publications

M R Wirthlin, and A R Vernino, and E B Hancock
March 1977, The Medical letter on drugs and therapeutics,
M R Wirthlin, and A R Vernino, and E B Hancock
January 1978, Obstetrics and gynecology,
M R Wirthlin, and A R Vernino, and E B Hancock
March 2018, Asian journal of surgery,
M R Wirthlin, and A R Vernino, and E B Hancock
September 1984, Plastic and reconstructive surgery,
M R Wirthlin, and A R Vernino, and E B Hancock
August 2015, American journal of orthopedics (Belle Mead, N.J.),
M R Wirthlin, and A R Vernino, and E B Hancock
April 1977, Journal of neurosurgery,
M R Wirthlin, and A R Vernino, and E B Hancock
June 1984, Clinical orthopaedics and related research,
M R Wirthlin, and A R Vernino, and E B Hancock
April 1952, L'union medicale du Canada,
M R Wirthlin, and A R Vernino, and E B Hancock
April 2008, Journal of biomedical materials research. Part B, Applied biomaterials,
M R Wirthlin, and A R Vernino, and E B Hancock
January 2018, JSLS : Journal of the Society of Laparoendoscopic Surgeons,
Copied contents to your clipboard!